Cargando…
Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review
Since the development of first lipid-based nanocarrier system, about 15% of the present pharmaceutical market uses nanomedicines to achieve medical benefits. Nanotechnology is an advanced area to meliorate the delivery of compounds for improved medical diagnosis and curing disease. Nanomedicines are...
Autores principales: | Maurya, Anand, Singh, Anurag Kumar, Mishra, Gaurav, Kumari, Komal, Rai, Arati, Sharma, Bhupesh, Kulkarni, Giriraj T., Awasthi, Rajendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Akadémiai Kiadó
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044564/ https://www.ncbi.nlm.nih.gov/pubmed/32148902 http://dx.doi.org/10.1556/1646.11.2019.04 |
Ejemplares similares
-
Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets
por: Singh, Anurag Kumar, et al.
Publicado: (2020) -
Lipid Nanoparticles as Carriers for Bioactive Delivery
por: Dhiman, Neerupma, et al.
Publicado: (2021) -
Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia
por: Sharma, Poonam, et al.
Publicado: (2021) -
Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease
por: Singh, Anurag Kumar, et al.
Publicado: (2021) -
Intranasally Co-administered Berberine and Curcumin
Loaded in Transfersomal Vesicles Improved Inhibition of Amyloid Formation
and BACE-1
por: Mishra, Gaurav, et al.
Publicado: (2022)